We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Owlstone Medical Raises $15 million USD to Drive Commercialization of its Breath Biopsy Platform

News   Mar 05, 2018 | Original story from Owstone Medical

 
Owlstone Medical Raises $15 million USD to Drive Commercialization of its Breath Biopsy Platform

Billy Boyle, CEO, Owlstone Medical

 
 
 

RELATED ARTICLES

Existing Drug Could Treat Porphyria

News

An existing antifungal drug, ciclopirox (CPX), has been shown to improve symptoms associated with congenital erythropoietic porphyria – the rarest type of porphyria.

READ MORE

Additional Evidence Shows HPV Vaccine is Safe

News

Further evidence has been generated to demonstrate the safety of the life-saving bivalent HPV vaccine.

READ MORE

UK-India Project Combats Infections Threat with Diagnostics

News

A £3 million interdisciplinary research project is to address the growing threat of drug-resistant infections in India.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE